Persisting toxicity related to prior therapy (NCI CTCAE v. Grade > )
Persisting toxicity related to prior therapy (NCI CTCAE v. . Grade > ); however, alopecia, sensory neuropathy Grade ? , or other Grade ?  not constituting a safety risk based on Investigator's judgment are acceptable.
Persisting toxicity related to prior therapy that has not reduced to grade  (National Cancer Institute Common Toxicity Criteria for Adverse Events [NCI CTCAE] version .); however, alopecia and sensory neuropathy grade =<  is acceptable.
Persisting toxicity related to prior therapy (National Cancer Institute [NCI] Common Terminology Criteria for Adverse Events [CTCAE] version [v]. . grade > ); however, alopecia, sensory neuropathy grade =< , or other grade =<  not constituting a safety risk based on investigator's judgement are acceptable
Persisting toxicity (except alopecia and vitiligo) related to prior oncologic therapy grade >  NCI-CTCAE v., however, sensory neuropathy grade =<  is acceptable.
All adverse events Grade >  related to prior therapies (chemotherapy, radiotherapy, and/or surgery) must be resolved to grade  or baseline, except for alopecia and sensory neuropathy Grade ? , or other Grade ?  not constituting a safety risk based on investigator's judgment, are acceptable.
Persisting toxicity related to prior therapy of grade >  NCI-CTCAE v .; however, alopecia and sensory neuropathy grade =<  is acceptable.
Persisting toxicity related to prior therapy >Grade 
Persisting toxicity related to prior therapy (NCI CTCAE v. . grade > ); however, alopecia, sensory neuropathy grade ? , or other grade ?  not constituting a safety risk based on investigators judgment are acceptable
All adverse events grade >  related to prior therapies (chemotherapy, radiotherapy, and/or surgery) must be resolved to grade  or baseline, except for alopecia and sensory neuropathy grade =< , or other grade =<  not constituting a safety risk based on investigators judgment, are acceptable
Persisting toxicity from prior therapy (National Cancer Institute [NCI] CTCAE v. grade >); however alopecia or other grade =<  adverse events (AEs) not constituting a safety risk, based on investigators judgement, are acceptable
Persisting toxicity related to prior therapy (Common Terminology Criteria for Adverse Events [CTCAE] > grade ); however, alopecia, sensory neuropathy =< grade , or other =< grade  not constituting a safety risk based on the investigators judgment are acceptable
Persisting toxicity related to prior therapy (NCI CTCAE v. . Grade > ); however, alopecia, sensory neuropathy grade =< , or other grade =<  not constituting a safety risk based on investigators judgment are acceptable.
Persisting toxicity related to prior therapy (NCI CTCAE v. . grade > ); however, alopecia, sensory neuropathy grade ? , or other grade ?  not constituting a safety risk based on investigators judgment are acceptable
Persisting toxicity related to prior therapy (National Cancer Institute [NCI] Common Terminology Criteria for Adverse Events [CTCAE] version [v.] . grade > ); however, alopecia, sensory neuropathy grade =< , grade  anemia, or other grade =<  not constituting a safety risk based on investigators judgment are acceptable
Persisting toxicity related to prior therapy of grade >  NCI-CTCAE v .; however, alopecia and sensory neuropathy grade =<  is acceptable
Persisting toxicity related to prior therapy (NCI CTCAE v. . grade > ); however, alopecia, sensory neuropathy grade =< , or other grade =<  not constituting a safety risk based on investigators judgment are acceptable
Persisting toxicity related to prior therapy of grade >  NCI-CTCAE v .; however, alopecia and sensory neuropathy grade =<  is acceptable
Persisting toxicity related to prior therapy (National Cancer Institute [NCI] Common Terminology Criteria for Adverse Events [CTCAE] version . [v.] grade > ); however alopecia, sensory neuropathy grade =< , or other grade =<  adverse events (AEs) not constituting a safety risk based on investigator's judgment are acceptable
Persisting toxicity related to prior therapy of grade >  NCI-CTCAE v .; however, alopecia and sensory neuropathy grade =<  is acceptable
Persisting toxicity related to prior therapy that has not reduced to grade  (National Cancer Institute Common Toxicity Criteria for Adverse Events [NCI CTCAE] version .); however, alopecia and sensory neuropathy grade =<  is acceptable
Persisting toxicity related to prior therapy of grade >  NCI-CTCAE v .; however, alopecia and sensory neuropathy grade =<  is acceptable
Persisting toxicity related to prior therapy Grade >.
Persisting toxicity related to prior therapy except alopecia
Persisting toxicity related to prior therapy Grade >  NCI-CTCAE v .; however, sensory neuropathy Grade <=  is acceptable . Pregnancy or lactation
Persisting ?Grade  CTCAE toxicity (except alopecia and Grade  peripheral neuropathy) from previous anti-cancer treatment(s)
Persisting toxicity related to prior therapy of grade >  NCI-CTCAE v .; however, alopecia, sensory neuropathy grade =<  or other grade =<  adverse events (AEs) not constituting a safety risk based on investigator's judgment are acceptable
Persisting toxicity related to prior therapy >Grade 
Participants who have had endocrine, chemotherapy, and/or biologic therapy <  days prior to entering the study or those who have not recovered from any prior treatment-related toxicities (must recover to no more than grade ; alopecia, sensory neuropathy grade =< , or other grade =<  toxicity not constituting a safety risk based on investigators judgment are acceptable)
Persisting toxicity related to prior therapy of NCI CTCAE grade > severity. Sensory neuropathy of grade ? is acceptable.
Persisting toxicity related to prior therapy (Grade > NCI CTCAE v.); however, alopecia, sensory neuropathy (Grade  or less), or other (Grade  or less) adverse events not constituting a safety risk based on the investigator's judgement are acceptable.
Persisting toxicity related to prior therapy (NCI CTCAE v. . grade > ); however, alopecia, sensory neuropathy grade =< , or other grade =<  not constituting a safety risk based on investigators judgment are acceptable
Persisting toxicity related to prior therapy of grade >  NCI-CTCAE v .; however, alopecia and sensory neuropathy grade =< , or other grade =<  not constituting a safety risk based on investigators judgment, are acceptable